1-1 of 1
Judith Goldberg, MD
Close
Sort by
Journal Articles

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Giovanni Barosi, MD, Elisabetta Gattoni, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD, Lewis Silverman, MD, Judith Goldberg, MD, Roberto Marchioli, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2007) 110 (11): 3540.
https://doi.org/10.1182/blood.V110.11.3540.3540
Published: 2007